BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

SCOLR Pharma, Inc. (DDD) Announces The Start Of Its Extended Release CDT-Pseudoephedrine Human Trials


10/19/2005 5:12:52 PM

BELLEVUE, Wash.--(BUSINESS WIRE)--March 1, 2005--SCOLR Pharma, Inc. (Amex:DDD) announced today that it has initiated human testing of its 12-hour Controlled Delivery Technology (CDT(R))-based pseudoephedrine tablets. The first of three planned U.S. studies was started on February 26, 2005. These studies are intended to support an anticipated Abbreviated New Drug Application submission to the Food and Drug Administration this summer. SCOLR Pharma had previously announced an agreement with UPM Pharmaceuticals for the manufacture of the pseudoephedrine tablets to be used in these human trails. This is the Company's second CDT-based formulation designed for the U.S. OTC (over-the-counter) market, the first being ibuprofen.

Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES